Kuldeep Singh Rajput is revolutionising the healthcare industry. His company Biofourmis is pioneering an entirely new category of medicine, developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. The company has raised more than US$145 million in funding since it was established in 2016.